185 related articles for article (PubMed ID: 37980123)
1. Relationship Between Multiple Sclerosis, Gut Dysbiosis, and Inflammation: Considerations for Treatment.
Jank L; Bhargava P
Neurol Clin; 2024 Feb; 42(1):55-76. PubMed ID: 37980123
[TBL] [Abstract][Full Text] [Related]
2. The gut microbiome molecular mimicry piece in the multiple sclerosis puzzle.
Elsayed NS; Aston P; Bayanagari VR; Shukla SK
Front Immunol; 2022; 13():972160. PubMed ID: 36045671
[TBL] [Abstract][Full Text] [Related]
3. Dysbiosis in Multiple Sclerosis: Can Immunoglobulin Y Supplements Help?
Paraschiv AC; Vacaras V; Nistor C; Vacaras C; Nistor DT; Vesa SC; Ilut S; Muresanu DF
J Gastrointestin Liver Dis; 2024 Mar; 33(1):115-122. PubMed ID: 38554422
[TBL] [Abstract][Full Text] [Related]
4. Pulmonary Arterial Hypertension Patients Have a Proinflammatory Gut Microbiome and Altered Circulating Microbial Metabolites.
Moutsoglou DM; Tatah J; Prisco SZ; Prins KW; Staley C; Lopez S; Blake M; Teigen L; Kazmirczak F; Weir EK; Kabage AJ; Guan W; Khoruts A; Thenappan T
Am J Respir Crit Care Med; 2023 Mar; 207(6):740-756. PubMed ID: 36343281
[No Abstract] [Full Text] [Related]
5. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
Sun MF; Shen YQ
Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
[TBL] [Abstract][Full Text] [Related]
6. The Gut-Brain Axis in Multiple Sclerosis. Is Its Dysfunction a Pathological Trigger or a Consequence of the Disease?
Parodi B; Kerlero de Rosbo N
Front Immunol; 2021; 12():718220. PubMed ID: 34621267
[TBL] [Abstract][Full Text] [Related]
7. Multiple Sclerosis-Associated Gut Microbiome in the Israeli Diverse Populations: Associations with Ethnicity, Gender, Disability Status, Vitamin D Levels, and Mediterranean Diet.
Nitzan Z; Staun-Ram E; Volkowich A; Miller A
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834472
[TBL] [Abstract][Full Text] [Related]
8. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
[TBL] [Abstract][Full Text] [Related]
9. The importance of gut-brain axis and use of probiotics as a treatment strategy for multiple sclerosis.
Kumar N; Sahoo NK; Mehan S; Verma B
Mult Scler Relat Disord; 2023 Mar; 71():104547. PubMed ID: 36805171
[TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis and faecal microbiome transplantation: are you going to eat that?
Wing AC; Kremenchutzky M
Benef Microbes; 2019 Feb; 10(1):27-32. PubMed ID: 30525949
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
Shabbir U; Arshad MS; Sameen A; Oh DH
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
[TBL] [Abstract][Full Text] [Related]
12. Detection of Dysbiosis and Increased Intestinal Permeability in Brazilian Patients with Relapsing-Remitting Multiple Sclerosis.
Pellizoni FP; Leite AZ; Rodrigues NC; Ubaiz MJ; Gonzaga MI; Takaoka NNC; Mariano VS; Omori WP; Pinheiro DG; Matheucci Junior E; Gomes E; de Oliveira GLV
Int J Environ Res Public Health; 2021 Apr; 18(9):. PubMed ID: 33925359
[TBL] [Abstract][Full Text] [Related]
13. Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.
Dai Y; Shen Z; Khachatryan LG; Vadiyan DE; Karampoor S; Mirzaei R
Pathol Res Pract; 2023 Sep; 249():154740. PubMed ID: 37567034
[TBL] [Abstract][Full Text] [Related]
14. The second brain: The connection between gut microbiota composition and multiple sclerosis.
Farshbafnadi M; Agah E; Rezaei N
J Neuroimmunol; 2021 Nov; 360():577700. PubMed ID: 34482269
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota dysbiosis and Huntington's disease: Exploring the gut-brain axis and novel microbiota-based interventions.
Sharma G; Biswas SS; Mishra J; Navik U; Kandimalla R; Reddy PH; Bhatti GK; Bhatti JS
Life Sci; 2023 Sep; 328():121882. PubMed ID: 37356750
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy.
Yadav SK; Ito K; Dhib-Jalbut S
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834203
[TBL] [Abstract][Full Text] [Related]
17. Interplay between diet, the gut microbiome, and atherosclerosis: Role of dysbiosis and microbial metabolites on inflammation and disordered lipid metabolism.
Anto L; Blesso CN
J Nutr Biochem; 2022 Jul; 105():108991. PubMed ID: 35331903
[TBL] [Abstract][Full Text] [Related]
18. Fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis and intestinal inflammation in multiple sclerosis.
Yadav SK; Ito N; Mindur JE; Kumar H; Youssef M; Suresh S; Kulkarni R; Rosario Y; Balashov KE; Dhib-Jalbut S; Ito K
Front Immunol; 2022; 13():1015372. PubMed ID: 36341389
[TBL] [Abstract][Full Text] [Related]
19. Role of the gut microbiome in multiple sclerosis: From etiology to therapeutics.
Shahi SK; Yadav M; Ghimire S; Mangalam AK
Int Rev Neurobiol; 2022; 167():185-215. PubMed ID: 36427955
[TBL] [Abstract][Full Text] [Related]
20. Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease.
Woodhouse CA; Patel VC; Singanayagam A; Shawcross DL
Aliment Pharmacol Ther; 2018 Jan; 47(2):192-202. PubMed ID: 29083037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
